Possibilities for using preparation surfactant-BL in the complex management of pulmonary tuberculosis

N. V. Chernichenko, L. E. Lepekha, O. V. Lovacheva, G. V. Evgushchenko, V. V. Erokhin (Moscow, Russia)

Source: Annual Congress 2004 - Management of infection and tuberculous diseases I
Session: Management of infection and tuberculous diseases I
Session type: Thematic Poster Session
Number: 3953
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. V. Chernichenko, L. E. Lepekha, O. V. Lovacheva, G. V. Evgushchenko, V. V. Erokhin (Moscow, Russia). Possibilities for using preparation surfactant-BL in the complex management of pulmonary tuberculosis. Eur Respir J 2004; 24: Suppl. 48, 3953

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of surgery in treating of firstly-found destructive pulmonary tuberculosis after ineffective DOTS-therapy
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009

Surgical treatment of pulmonary tuberculosis
Source: Eur Respir Monogr 2013; 61: 20-36
Year: 2013


Surgical treatment of first-found destructive pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012

Contribution of invasive methods in the diagnosis of pulmonary tuberculosis
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019

Aspects of diagnosis and treatment in pulmonary tuberculosis in children
Source: Eur Respir J 2002; 20: Suppl. 38, 168s
Year: 2002

Complex treatment of widespread destructive pulmonary tuberculosis using innovative technology of the main bronchial stump treatment during pneumonectomy
Source: Virtual Congress 2021 – Rare thoracic surgical disease and the chest wall
Year: 2021


Surgical treatment of combination of tuberculosis and pulmonary echinococcosis
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011

Effects of complex treatment with izofon of a pulmonary tuberculosis in children
Source: Eur Respir J 2004; 24: Suppl. 48, 652s
Year: 2004

Safety aspects of endobronchial valve application in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012

Atypical aspects of pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 507s
Year: 2006

Unusual forms of pulmonary tuberculosis
Source: Annual Congress 2011 - Management of tuberculosis
Year: 2011

Effectiveness of thoracoplasty at disseminated drug-resistant fibrous-cavernous pulmonary tuberculosis
Source: Annual Congress 2010 - Special treatment options in tuberculosis
Year: 2010

Diagnosis and treatment‘s management of the MDR tuberculosis in a chronic pulmonary diseases department
Source: Eur Respir J 2005; 26: Suppl. 49, 651s
Year: 2005

Differential diagnosis of destructive pulmonary tuberculosis in real clinical practice
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020


Phytotherapy in complex treatment of destructive tuberculosis of the lungs
Source: Eur Respir J 2005; 26: Suppl. 49, 646s
Year: 2005

Surgical approach to multidrug-resistant pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 323s
Year: 2003

Application of the endobronchial valve and miniinvasive collapsosurgical operations in the complex treatment of drug-resistant lung tuberculosis
Source: Annual Congress 2008 - Surgical treatment of lung tuberculosis
Year: 2008

Diagnosis and treatment delay in patients with pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 520s
Year: 2003

Effectiveness of complex treatment of bilateral destructive pulmonary XDR-tuberculosis
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021